Transmission of Hepatitis C Virus During Colonoscopy (Letter) CDC Daily UpdateImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Transmission of Hepatitis C Virus During Colonoscopy (Letter)

New England Journal of Medicine (12/18/97) Vol. 337, No. 25, P. 1849
Bronowicki, Jean-Pierre; Bigard, Marc-Andre


Abstract: In response to a letter to the editor of the New England Journal of Medicine, Jean-Pierre Bronowicki and Marc-Andre Bigard of France's Centre Hospitalier Universitaire de Nancy support the author's assertion that gastrointestinal endoscopy is safe when the recommended procedures are followed. Bronowicki and Bigard also note that the probability of a hepatitis C outbreak from endoscopy is unlikely if all proper procedures are followed, considering the fact that the virus itself is enveloped. Still, the authors recognize that the low incidence of reported viral hepatitis C infection after endoscopy could be due to the difficulty of recognizing acute hepatitis C in most cases. Given these issues, the authors explain that their study was intended to help physicians realize the risk of hepatitis C transmission when inadequate disinfection procedures are used for endoscopy. They also attempted to address the risk of cross-infection related to the repeated use of disposable syringes by anesthetists--a common practice, the authors found, despite the publication of recommended infection-control procedures for anesthesiology.


971218
AD972313


Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.